Characterization of nanoparticle-mediated drug delivery to NB4: Feasibility of nanoparticle use for cells in suspension and blood diseases

Journal of Biomedical Nanotechnology

Volumn 4, Issue 2, 2008, Pages 196-202

  Kafka, E L ^a   Braden, A ^a   Vishwanatha, J K ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Acute promyelocytic Leukemia; Nanoparticle; PLGA; Retinoic acid

Indexed keywords

NANOPARTICLE; POLYGLACTIN; RETINOIC ACID;

ARTICLE; CELL SUSPENSION; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; FEASIBILITY STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR MECHANICS; NANOENCAPSULATION; NANOTECHNOLOGY; PROMYELOCYTIC LEUKEMIA; SUSTAINED RELEASE FORMULATION;

EID: 58149092671     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. A. Kakizuka, W. H. Miller, Jr., K. Umesono, R. P. Warrel, Jr., S. R. Frankel, V. V. Murty, E. Dmitrovsky, and R. M. Evans, Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663 (1991).
2. F. Grignani, P. F. Ferrucci, U. Testa, G. Talamo, M. Fagioli, M. Alcalay, A. Mencarelli, F. Grignani, C. Peschle, and I. Nicoletti, The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74, 423 (1993).
3. J. M. Benett, D. Catoysky, M. T. Daniel, G. Flandrin, D. A. Galton, H. R. Gralnick, and C. Sultan, Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br. J. Haematol. 33, 451 (1976).
4. G. B. Zhou, G. Li, S. J. Chen, and Z. Chen, From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: Leukemia research in the genomic era. Acta Pharmacol. Sin. 28, 1434 (2007).
5. L. Ades, M. A. Sanz, S. Chevret, P. Montesinos, P. Chevallier, E. Raffoux, E. Vellenga, A. Guerci, A. Pigneux, F. Huguet, C. Rayon, A. M. Stoppa, J. de La Sema, J. Y. Cahn, S. Meyer-Monard, T. Pabst, X. Thomas, S. de Botton, R. Parody, J. Bergua, T. Lamy, A. Vekhoff, S. Negri, N. Ifrah, H. Dombret, A. Ferrant, D. Bron, L. Degos, and P. Fenaux, Treatment of newly diagnosed acute promyelocytic leukemia (APL): A comparison of French-Belgian-Swiss and PETHEMA results. Blood 111, 1078 (2008).
6. P. Fenaux and L. Degos, Treatment of acute promyelocytic leukaemia. Baillieres Clin. Haematol. 9, 107 (1996).
7. P. Fenaux, C. Chastang, S. Chevret, M. Sanz, H. Dombret, E. Archimbaud, M. Fey, C. Rayon, F. Huguet, J. J. Sotto, C. Gardin, P. C. Makhoul, P. Travade, E. Solary, N. Fegueux, D. Bordessoule, J. S. Miguel, H. Link, B. Desablens, A. Stamatoullas, E. Deconinck, F. Maloisel, S. Castaigne, C. Preudhomme, and L. Degos, A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL group. Blood 94, 1192 (1999).
8. F. Lo-Coco and E. Ammatuna, The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment. Hematology Am. Soc. Hematol. Educ. Program 156-61, 514 (2006).
9. S. Castaigne, C. Chomienne, M. T. Daniel, P. Ballerini, R. Berger, P. Fenaux, and L. Degos, All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. clinical results. Blood 76, 1704 (1990).
10. S. S. R. Frankel, A. Eardley, G. Heller, E. Berman, W. H. Miller, Jr., E. Dmitroysky, and R. P. Warrell, Jr., All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York study. Ann. Intern. Med. 120, 278 (1994).
11. M. E. Huang, Y. C. Ye, S. R. Chen, J. R. Chai, J. X. Lu, L. Zhoa, L. J. Gu, and Z. Y. Wang, Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567 (1988).
12. C. Chomienne, P. Ballerini, N. Balitrand, M. T. Daniel, P. Fenaux, S. Castaigne, and L. Degos, All-trans retinoic acid in acute promyelocytic leukemias. II. in vitro studies: Structure-function relationship. Blood 76, 1710 (1990).
13. C. Chomienne, N. Balitrand, P. Ballerini, S. Castaigne, H. de The, and L. Degos, All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. J. Clin. Invest. 88, 2150 (1991).
14. J. Panyam and V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329 (2003).
15. J. Panyam, W. Z. Zhou, S. Prabha, S. K. Sahoo, and V. Labhasetwar, Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J. 16, 1217 ( 2002).
16. K. Y. Win and S. S. Feng, Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26, 2713 (2005).
17. A. Braden, A. Kashyap, J. Vasir, V. Labhasetwar, and J. K. Vishwanatha, Polymeric nanoparticles for sustained down-regulation of annexin A2 lead to reduction in proliferation and migration of prostate cancer cells. J. Biomed. Nanotechnol. 3, 1 (2007).
18. Y. L. Jeong, J. G. Song, S. S. Kang, H. H. Ryu, Y. H. Lee, C. Choi, B. A. Shin, K. K. Kim, K. Y. Ahn, and S. Jung, Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid. Int. J. Pharm. 259, 79 (2003).
19. Y. Cirpanli, N. Unlu, S. Calis, and A. A. Hincal, Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres. J. Microencapsul. 22, 877 (2005).
20. G. G. Giordano, M. F. Refojo, and M. H. Arroyo, Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. Invest. Ophthalmol. Vis. Sci. 34, 2743 (1993).
21. A. S. Zahr, C. A. Davis, and M. V. Pishko, Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 22, 8178 (2006).
22. S. Levenberg, N. F. Huang, E. Lavik, A. B. Rogers, J. Itskovitz-Eldor, and R. Langer, Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc. Natl. Acad. Sci. USA 100, 12741 (2003).
23. K. D. Newman and M. W. McBurney, Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells. Biomaterials 25, 5763 (2004).